MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
AUPH
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Aurinia Pharmaceuticals (AUPH) Ownership - Who owns Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
14315 - 118 Avenue
Phone
+1 250 744-2487
Employees
128
Web
https://www.auriniapharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.08B
P/E Ratio
7.48
Total Cash
378.78M
Projected Growth
N/A
Total Debt
68.64M
Revenue
298.3M
Risk (Beta)
0.74
Dividend Yield
N/A
Total Cash/Share
2.95
Total Debt/Equity
N/A
Revenue/Share
2.17 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
AUPH
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for AUPH
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
14315 - 118 Avenue
Phone
+1 250 744-2487
Employees
128
Web
https://www.auriniapharma.com